Impact of Substance Use Disorder on Midterm Mortality After Valve Surgery for Endocarditis
- 16 October 2019
- journal article
- research article
- Published by Elsevier BV in The Annals of Thoracic Surgery
- Vol. 109 (5), 1426-1432
- https://doi.org/10.1016/j.athoracsur.2019.09.004
Abstract
No abstract availableFunding Information
- National Institutes of Health
- National Center for Advancing Translational Science (1KL2-TR-002545-01)
This publication has 35 references indexed in Scilit:
- “It’s been an Experience, a Life Learning Experience”: A Qualitative Study of Hospitalized Patients with Substance Use DisordersJournal of General Internal Medicine, 2016
- Medication‐assisted treatment for hospitalized patients with intravenous‐drug‐use related infective endocarditisThe American Journal on Addictions, 2016
- Surgical outcomes of infective endocarditis among intravenous drug usersThe Journal of Thoracic and Cardiovascular Surgery, 2016
- Suboptimal Addiction Interventions for Patients Hospitalized with Injection Drug Use-Associated Infective EndocarditisThe American Journal of Medicine, 2015
- Tricuspid Valve Surgery in Patients with Isolated Tricuspid Valve Endocarditis: Analysis of Perioperative Parameters and Long-Term OutcomesThe Thoracic and Cardiovascular Surgeon, 2015
- Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of ComplicationsCirculation, 2015
- Injection Drug Use and Outcomes After Surgical Intervention for Infective EndocarditisThe Annals of Thoracic Surgery, 2015
- When Is Enough Enough? The Dilemma of Valve Replacement in a Recidivist Intravenous Drug UserThe Annals of Thoracic Surgery, 2014
- Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st CenturyJAMA Internal Medicine, 2009
- Mortality from infective endocarditis: clinical predictors of outcomeHeart, 2002